Back to search
FDAFDA · Food and drugs·Recall number Z-1463-2025

Medline procedure kits labeled as: 1) ANGIOGRAPHY SPECIALS

Published April 2, 2025 · Recall initiated: February 11, 2025

Summary

FDA records medical device Class II recall Z-1463-2025, published April 2, 2025 and initiated February 11, 2025. Recalling firm: MEDLINE INDUSTRIES, LP - Northfield; Status: Ongoing; Reported quantity: 1152 units; Lot: 1) Pack Number DYNJ60655D: UDI/DI 10195327464783 (each), 40195327464784 (case), Lot Number 24AMC692A. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Medical convenience kits contain plastic syringes affected by the FDA Safety Alert issued on March 19, 2024. Leaks, breakage, and/other quality issues have been identified that may pose a risk to patient health.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
MEDLINE INDUSTRIES, LP - Northfield
Distributor
Worldwide distribution - US Nationwide and the country of Canada.
Lot
1) Pack Number DYNJ60655D: UDI/DI 10195327464783 (each), 40195327464784 (case), Lot Number 24AMC692A
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Medline procedure kits labeled as: 1) ANGIOGRAPHY SPECIALS recalled?

Yes. FDA published recall Z-1463-2025 on April 2, 2025. Reported hazard: Medical convenience kits contain plastic syringes affected by the FDA Safety Alert issued on March 19, 2024. Leaks, breakage, and/other quality issues have been identified that may pose a risk to patient health.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit